1. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002; 35:519–524.
2. Rossi S, Buscarini E, Garbagnati F, Di Stasi M, Quaretti P, Rago M, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol. 1998; 170:1015–1022.
3. Bai XM, Yang W, Zhang ZY, Jiang AN, Wu W, Lee JC, et al. Longterm outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer. Int J Hyperthermia. 2019; 35:183–193.
4. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003; 226:441–451.
5. Rhim H, Yoon KH, Lee JM, Cho Y, Cho JS, Kim SH, et al. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics. 2003; 23:123–134. ; discussion 134-136.
6. Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol. 2011; 21:2584–2596.
7. Bae JH, Kim GC, Ryeom HK, Jang YJ. Percutaneous embolization of persistent biliary and enteric fistulas with Histoacryl. J Vasc Interv Radiol. 2011; 22:879–883.
8. York JA. Treating bronchopleural fistulae percutaneously with Nbutyl cyanoacrylate glue. J Vasc Interv Radiol. 2013; 24:1581–1583.
9. Nunes TF, de Santi GF. Percutaneous embolization of a colonic fistula using n-butyl-2 cyanoacrylate (Histoacryl[R]). Tech Coloproctol. 2017; 21:763–765.
10. Lopes MF, Catré D, Reis A, Leitão LM. Endoscopic treatment of recurrent tracheoesophageal fistula with histoacryl glue. Gastrointest Endosc. 2010; 72:1324–1325. ; author reply 1325.